Patents by Inventor Heather Stefanski

Heather Stefanski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for preventing and treating graft versus host disease
    Patent number: 11471517
    Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: October 18, 2022
    Assignees: The University of North Carolina at Chapel Hill, Regents of the University of Minnesota
    Inventors: Jonathan Serody, James Coghill, Danny Bruce, Bruce Blazar, Heather Stefanski, Benjamin Vincent
  • COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING GRAFT VERSUS HOST DISEASE
    Publication number: 20200155656
    Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.
    Type: Application
    Filed: October 10, 2019
    Publication date: May 21, 2020
    Inventors: Jonathan Serody, James Coghill, Danny Bruce, Bruce Blazar, Heather Stefanski, Benjamin Vincent
  • TYPE 2 INNATE LYMPHOID CELLS AND METHODS OF ENRICHING AND GROWING
    Publication number: 20190125800
    Abstract: Described herein are methods of enriching and growing Type 2 innate lymphoid cells.
    Type: Application
    Filed: October 31, 2018
    Publication date: May 2, 2019
    Inventors: Yan Xing, Heather Stefanski, Bruce Blazar
  • COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING GRAFT VERSUS HOST DISEASE
    Publication number: 20170360907
    Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.
    Type: Application
    Filed: December 4, 2015
    Publication date: December 21, 2017
    Inventors: Jonathan Serody, James Coghill, Danny Bruce, Bruce Blazar, Heather Stefanski, Benjamin Vincent